Microprofit Biotech Concludes a Successful Showcase at ADLM 2025

Microprofit Biotech is pleased to announce the successful conclusion of our participation in ADLM 2025 (Association for Diagnostics & Laboratory Medicine Annual Meeting & Clinical Lab Expo), held in Chicago. The exhibition once again proved to be one of the world’s leading events for in vitro diagnostics (IVD), connecting top distributors, partners, and healthcare professionals across the global diagnostic industry.

Show Highlights

At Booth #1049, Microprofit Biotech presented our latest Respiratory Infection Rapid Test Solution and the advanced FIA Quantitative POCT Platform, both designed to meet the evolving needs of clinical laboratories, diagnostic centers, and IVD distributors worldwide.

• Respiratory Infection Rapid Test Solution — provides a comprehensive, multi-pathogen detection portfolio for influenza, RSV, adenovirus, Mycoplasma pneumoniae, and other respiratory pathogens, enabling accurate results within minutes and facilitating early clinical decision-making.

• FIA Quantitative POCT Platform — our compact and intelligent fluorescent immunoassay (FIA) system supports quantitative detection of multiple biomarkers for infection, inflammation, and chronic disease management, delivering laboratory-level accuracy at the point of care.

Both solutions drew great attention from global IVD distributors seeking high-performance rapid test kits, immunofluorescence assays, and open POCT platforms adaptable to various healthcare settings.

Connecting with Global IVD Partners

Throughout the event, our team engaged with IVD distributors, reagent importers, OEM/ODM partners, and diagnostic solution providers from around the world. Discussions focused on distribution partnerships, technology collaboration, and localized marketing strategies for international markets.

ADLM 2025 provided a valuable platform for professionals across the clinical chemistry, immunodiagnostics, molecular diagnostics, and point-of-care testing (POCT) fields to exchange insights on product innovation, regulatory compliance (IVDR/CLIA), and market access.

Strengthening the IVD Supply Chain

Microprofit Biotech remains committed to providing complete IVD solutions—from raw materials and core reagents to ready-to-use test kits and smart diagnostic devices. Our goal is to empower distributors and healthcare providers with reliable, high-quality diagnostic tools that support timely, accurate, and affordable testing.

We sincerely thank all the visitors who stopped by our booth and look forward to building long-term partnerships with distributors, laboratories, and healthcare institutions across the globe.